Showing results (21-30 of 69) with videos related to

Sort By:
Pageof 7
International Journal of Cancer|December 5, 2022
The CHK2 kinase is recurrently mutated and functionally impaired in the germline of pediatric cancer patientsRabea Wagener, Carolin Walter, Franziska Auer, et al.
European Journal of Haematology|March 6, 2026
Prophylactic Donor Lymphocyte Infusions in Pediatric Patients With High-Risk Hematological MalignanciesDenise Epple, Katja Gall, Luisa Paschke, et al.
Seminars in Cancer Biology|February 18, 2014
Tumoral stem cell reprogramming as a driver of cancer: Theory, biological models, implications in cancer therapyCarolina Vicente-Dueñas, Julia Hauer, Lucía Ruiz-Roca, et al.
Psycho-Oncology|January 21, 2022
Illness perceptions in patients and parents in paediatric oncology during acute treatment and follow-up careKristina Herzog, Florian Schepper, Remo Kamm, et al.
British Journal of Haematology|July 9, 2013
Anti-leukaemic activity of a novel haploidentical-transplantation approach employing unmanipulated bone marrow followed by CD6-depleted peripheral blood stem cells in children with refractory/relapsed acute leukaemiaFriedhelm R Schuster, Roland Meisel, Monika Führer, et al.
Frontiers in Endocrinology|March 12, 2020
Cancer Stem Cells in Pheochromocytoma and ParagangliomaLaura D Scriba, Stefan R Bornstein, Alice Santambrogio, et al.
Journal of Medicinal Chemistry|October 27, 2018
Discovery of the First-in-Class Dual Histone Deacetylase-Proteasome InhibitorSanil Bhatia, Viktoria Krieger, Michael Groll, et al.
Cancers|November 26, 2022
T Cells Directed against the Metastatic Driver Chondromodulin-1 in Ewing Sarcoma: Comparative Engineering with CRISPR/Cas9 vs. Retroviral Gene Transfer for Adoptive TransferBusheng Xue, Kristina von Heyking, Hendrik Gassmann, et al.
Journal of Medicinal Chemistry|August 18, 2020
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping GroupsNina Reßing, Melf Sönnichsen, Jeremy D Osko, et al.
Frontiers in Immunology|February 6, 2024
TCR-transgenic T cells and YB-1-based oncolytic virotherapy improve survival in a preclinical Ewing sarcoma xenograft mouse modelSebastian J Schober, Melanie Thiede, Hendrik Gassmann, et al.
Pageof 7